All in on AI, Accountable to Outcomes
Accountability is a cornerstone in our approach to Responsible AI.
Our Latest News
Our Science
May 22, 2024
Digital “Twinning”: Clinical Trials Powered by AI
United by Purpose
Each of us plays a unique role in bringing our purpose to life.
Sanofi X Paris 2024
We’re proud to be premium partner of Paris 2024.
Science and sport aren’t that different. Just like athletes do, we overcome setbacks to keep moving forward, not just for ourselves, but for our patients, colleagues, families and friends.
About Us
Who We Are
We are an innovative global healthcare company.
Our Pipeline
5
Therapeutic areas
77
Compounds in clinical development
28
Clinical trials in phase 3
Explore Career Opportunities
You'll be surprised what you can achieve at Sanofi. Discover your future here.
Our Latest Press Releases
May 22, 2024
Media Update: New results from rilzabrutinib phase 2 study show potential to be first advanced oral treatment for moderate-to-severe asthma
May 21, 2024
Press Release: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration
May 20, 2024
Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM
May 13, 2024
Press Release: Sanofi adds over €1 billion for biomanufacturing to €2.5 billion already committed in major projects in France to support health sovereignty